Since 2015, Thyroid Association of NZ (TANZi) has tried to engage endocrinologists and chemical pathologists who write NZ guidelines, lab testing policies and medical training so that issues for patients can be resolved. In 2018, TANZi told a local Member of Parliament that no-one would talk to them, and they were advised to petition parliament. See … Continue reading New Zealand thyroid patients’ petition milestones achieved
They say that history is written by the victors. Not always. Sometimes histories are written by advocates for the oppressed and disenfranchised. A common theme on our website is the need to see current practices and thyroid therapy challenges in light of thyroid therapy history. Instead of trusting histories written by scientists, one ought to … Continue reading Mimicry: The idol of T3-T4 combo therapy 2004-2014
There's no surprise that patients and doctors would disagree about the incidence rate of hypothyroid symptoms in a given patient. "We have an average of 7.2 symptoms per patient" says the cohort of 262 patients. "No, you have an average of 4.0 symptoms per patient," says the cohort of 100 doctors about those 262 patients. … Continue reading Discordance in thyroid symptoms reported by patients and their doctors
This week (as of October 4, 2019), a thyroid patient from British Columbia posted an image of a piece of paper handed to her at a LifeLabs laboratory. LifeLabs BC was using this paper leaflet to explain to her why "Free T3 and Free T4 will not be tested when the TSH is in reference … Continue reading LifeLabs BC handout reveals thyroid testing policy failure
This post engages in a moral argument, not a scientific one. Thyroid pharmaceutical prejudice is part of a paradigm that is refusing to shift. We need to keep asking key questions and fight together for this shift. Look around you today. Thyroid guidelines and health care systems currently treat all thyroid patients as one undifferentiated … Continue reading Pharma prejudice refuses a paradigm shift in thyroid therapy
